{"id":62647,"title":"IQ-AI Limited (LON:IQAI) FDA Clearance to Market for StoneChecker Software","publisher":"Share Talk","author":"sharetalk","published":"2019-09-27T15:13:16+00:00","modified":"2019-09-27T15:13:16+00:00","canonical_url":"https://www.share-talk.com/iq-ai-limited-loniqai-fda-clearance-to-market-for-stonechecker-software/","markdown_url":"https://www.share-talk.com/iq-ai-limited-loniqai-fda-clearance-to-market-for-stonechecker-software.md","json_url":"https://www.share-talk.com/iq-ai-limited-loniqai-fda-clearance-to-market-for-stonechecker-software.json","category":"Technology, Media & Telecoms","categories":["Technology, Media & Telecoms"],"tags":["IQ-AI Limited","IQAI"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"IQ-AI Announce FDA ‘Clearance to Market’ For StoneChecker Software\n\nImaging Biometrics, IQ-AI’s Milwaukee based subsidiary, today received notification that the FDA has cleared StoneChecker Software for marketing in the USA.\n\nDavid Smith, Chief Executive of the operating subsidiaries of IQ-AI stated, “We are delighted that after an exhaustive review of the product, that the FDA has cleared the product for marketing in the USA.”\n\nA further announcement will be issued in the next few days, outlining the scale of the market opportunity for the product in the USA and IQ-AI’s plans for introduction.\n\nThe Directors of the Company accept responsibility for the contents of this announcement.\n\n \n\n-ENDS-\n\n "}